Paranovus Entertainment Technology Ltd
NASDAQ:PAVS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Paranovus Entertainment Technology Ltd
Retained Earnings
Paranovus Entertainment Technology Ltd
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Paranovus Entertainment Technology Ltd
NASDAQ:PAVS
|
Retained Earnings
-$70.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Shenzhen Breo Technology Co Ltd
SSE:688793
|
Retained Earnings
¥28m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
D
|
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
|
Retained Earnings
¥287.9m
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Minsheng Healthcare Co Ltd
SZSE:301507
|
Retained Earnings
¥222.4m
|
CAGR 3-Years
418%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
Retained Earnings
¥2.1B
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Runben Biotechnology Co Ltd
SSE:603193
|
Retained Earnings
¥660.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Paranovus Entertainment Technology Ltd
Glance View
Paranovus Entertainment Technology Ltd. engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in the People's Republic of China and internationally. The company is headquartered in Nanping, Fujian and currently employs 218 full-time employees. The company went IPO on 2019-10-25. The firm's main businesses are the research and development, manufacturing and sales of nutritional products made from traditional Chinese medicine and animal extracts. The firm's main products include spore powder, cordyceps mycelium products, donkey-hide gelatin solution products, vitamins and dietary supplement products, American ginseng products and other nutrition products. The firm also engages in e-commerce and auto sales through the platforms Happy Buy and Taochejun.
See Also
What is Paranovus Entertainment Technology Ltd's Retained Earnings?
Retained Earnings
-70.9m
USD
Based on the financial report for Sep 30, 2025, Paranovus Entertainment Technology Ltd's Retained Earnings amounts to -70.9m USD.
What is Paranovus Entertainment Technology Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 1Y
-11%
Over the last year, the Retained Earnings growth was -11%.
